Nerve block showdown: which technique spares kids from opioids after surgery?
NCT ID NCT07711496
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This trial compares two ultrasound-guided nerve blocks—anterior quadratus lumborum block and retrolaminar block—for pain relief in children aged 6 months to 12 years undergoing lower urogenital surgery. Both blocks use the numbing medicine bupivacaine. The study measures how much extra pain medicine is needed in the first 24 hours after surgery, along with pain scores and side effects. The goal is to find which block provides better pain control and reduces opioid use.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- two ultrasound-guided nerve blocks: anterior quadratus lumborum block and retrolaminar block, both using bupivacaine
- What this could lead to
- If one block proves better, it could become the standard for pain control in children after lower urogenital surgery, reducing opioid needs and speeding recovery.
- What could go wrong
- This is a small, single-center trial, so results may not apply to all hospitals or surgeries. Both blocks are already used, so the difference may be small or not clinically meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 76 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 months to 12 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 6 months and 12 years * Scheduled for lower abdominal urogenital surgery (e.g., inguinal hernia repair or orchiopexy for undescended testis) * American Society of Anesthesiologists physical status classification I-III * Written informed consent obtained from a parent or legal guardian Exclusion Criteria: * History of allergy to local anesthetic agents * Presence of infection at the planned injection site * Coagulopathy or any other condition contraindicating regional anesthesia * Planned laparoscopic orchiopexy * American Society of Anesthesiologists physical status classification IV * Inability to obtain informed consent from a parent or legal guardian * Anticipated requirement for postoperative intensive care unit admission
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pediatric postoperative pain are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty
Bakırköy, Istanbul, 34153, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.